CIK 0001620737 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in Z4 · fiscal year ends 09/30
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-15 | 6-K | 6-K | 2026-10-15 |
| 2026-09-30 | 6-K | 6-K | 2026-09-30 |
| 2026-09-03 | 6-K | 6-K | 2026-09-30 |
| 2026-09-01 | 6-K | FORM 6-K | 2026-02-18 |
| 2026-08-20 | 6-K | 6-K | 2026-08-20 |
| 2026-08-11 | 6-K | 6-K | 2026-06-30 |
| 2026-08-04 | 6-K | 6-K | 2026-08-04 |
| 2026-07-20 | 6-K | 6-K | 2026-07-20 |
| 2026-05-12 | 6-K | 6-K | 2026-03-31 |
| 2026-05-06 | 6-K | 6-K | 2026-05-06 |
| 2026-04-17 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-04-16 | 6-K | 6-K | 2026-04-15 |
| 2026-03-31 | 6-K | 6-K | 2026-03-30 |
| 2026-03-23 | 6-K | 6-K | 2026-03-23 |
| 2026-03-11 | 6-K | 6-K | 2026-03-10 |
| 2026-03-09 | 6-K | FORM 6-K | 2026-02-23 |
| 2026-03-05 | 6-K | 6-K | 2026-03-05 |
| 2026-03-03 | 6-K | 6-K | 2026-03-03 |
| 2026-02-24 | 6-K | 6-K | 2026-02-24 |
| 2026-02-20 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-02-20 | 6-K | 6-K | 2026-02-20 |
| 2026-02-20 | 6-K | 6-K | 2026-02-19 |
| 2026-02-19 | 6-K | 6-K | 2026-02-19 |
| 2026-02-18 | 6-K | 6-K | 2026-02-18 |
| 2026-02-10 | 6-K | 6-K | 2025-12-31 |
Forms on file (last 1,000): 6-K 257, SC 13G/A 9, 40-F 7, D 7, SC 13D/A 5, SUPPL 5, FWP 4, F-X 4. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=OGI (0.002 USD), /gw/filings/filings?ticker=OGI&form=8-K, /gw/filings/facts?ticker=OGI&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange